Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives

E-ISSN： 1873-5576|11|1|85-102

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.1, 2011-01, pp. : 85-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer vaccines entering Phase III clinical trials

By Durrant LG Spendlove I

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 489-500

Informa Healthcare

Access to resources Recommend Favorite

Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials

By Stallard Nigel

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 787-801

Taylor & Francis Ltd

Access to resources Recommend Favorite

Recent and current Phase II clinical trials in endometrial cancer: review of the state of art

By Lheureux Stephanie Wilson Michelle Mackay Helen J

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. : 773-792

Informa Healthcare

Access to resources Recommend Favorite

The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3853-3858

Blackwell Publishing

Access to resources Recommend Favorite

Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine: Analysis of a Single-Dose Phase I Study and Pooled Steady-State Data from Phase II/III Trials

By Lobo Evelyn D.

Clinical Pharmacokinetics, Vol. 49, Iss. 5, 2010-05 ,pp. : 311-321

Adis International

Access to resources Recommend Favorite